Attorney General Lockyer Announces $14 Million National Settlement with GlaxoSmithKline to Resolve Patent Fraud, Antitrust Allegations

Attorney General Lockyer Announces $14 Million National Settlement with GlaxoSmithKline to Resolve Patent Fraud, Antitrust Allegations: "Attorney General Bill Lockyer today announced pharmaceutical giant GlaxoSmithKline (GSK) will pay $14 million to resolve allegations that state-government programs paid inflated prices for the firm�s anti-depressant drug Paxil because GSK engaged in patent fraud, antitrust violations and frivolous litigation to maintain a monopoly and block generic versions from entering the market."